Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

KANWAL SINGH

NPI
1184668097
CMS profile
1307637
Location
MADERA, CA

General Payments · PY2019–2025

$3,433.71

  • Reported across 85 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$681.29

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $681.29 14

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $245.22 3
Bayer HealthCare Pharmaceuticals Inc. $187.29 4
Lilly USA, LLC $111.15 1
Janssen Pharmaceuticals, Inc $53.84 2
ABIOMED $38.52 2
CHIESI USA, INC. $25.71 1
Acerta Pharma LLC $19.56 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $356.90 10
PY2020 $109.44 6
PY2021 $123.95 7
PY2022 $206.90 5
PY2023 $788.21 18
PY2024 $1,167.02 25
PY2025 $681.29 14

Payment records · PY2025 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABIOMED $15.33 02/21/2025 Food and Beverage Undisputed 06/30/2026 1174438215 CMS
ABIOMED $23.19 07/31/2025 Food and Beverage Undisputed 06/30/2026 1174438159 CMS
Amgen Inc. $8.67 01/13/2025 Food and Beverage Undisputed 06/30/2026 1227083202 CMS
Amgen Inc. $125.00 02/12/2025 Food and Beverage Undisputed 06/30/2026 1228289603 CMS
Amgen Inc. $111.55 09/04/2025 Food and Beverage Undisputed 06/30/2026 1228289605 CMS
AstraZeneca Pharmaceuticals LP $19.56 10/13/2025 Food and Beverage Undisputed 06/30/2026 1214796087 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.57 03/14/2025 Food and Beverage Undisputed 06/30/2026 1225804171 CMS
Bayer Healthcare Pharmaceuticals Inc. $121.82 06/14/2025 Food and Beverage Undisputed 06/30/2026 1225804183 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.71 08/09/2025 Food and Beverage Undisputed 06/30/2026 1225804175 CMS
Bayer Healthcare Pharmaceuticals Inc. $23.19 10/29/2025 Food and Beverage Undisputed 06/30/2026 1225804179 CMS
Chiesi USA, Inc. $25.71 08/25/2025 Food and Beverage Undisputed 06/30/2026 1242167101 CMS
Janssen Pharmaceuticals, Inc $26.92 04/03/2025 Food and Beverage Undisputed 06/30/2026 1174268840 CMS
Janssen Pharmaceuticals, Inc $26.92 04/03/2025 Food and Beverage Undisputed 06/30/2026 1174268853 CMS
Lilly USA, LLC $111.15 03/26/2025 Food and Beverage Undisputed 06/30/2026 1186716155 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.